Skip to content

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain - Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029968
Enrollment
80
Registered
2017-11-15
Start date
2017-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cedar pollinosis

Interventions

Take two capsules containing lactic acid bacteria a day Take two placebo capsules a day

Sponsors

Department of Otolaryngology, Wakayama Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Adult male and female from 20 to 60 years old (2) Subjects who can take capsules

Exclusion criteria

Exclusion criteria: (1) Subjects with symptoms of hay fever except cedar pollinosis at the stage of screening conducted from November 2017 to January 2018 (2) Subjects who regularly drink or eat live fungus-containing foods including lactic acid bacteria beverage, food,and preparation, and Bacillus natto (3) Subjects smorking (4) Pregnant women, lactating women, or women who want to get pregnant during the trial period (5)Subjects who show hypersensitivity symptoms to lactic acid bacteria foods (6) Subjects who investigator judge not suitable to participate in the trial

Design outcomes

Primary

MeasureTime frame
Change of s-IgA secreation

Secondary

MeasureTime frame
(1)Time course of s-IgA in saliva (2)Number of infections of influenza and viral emesis diarrhea (3)POMS 2 (mood profile test) (4)Stool frequency (5)Characteristics of stool (6)Organic acid in stool (7)Bacterial flora in stools The evaluation items below are done in the cedar pollinosis group (8)Specific IgE (cedar) concentration in blood (9)Nasal symptom score

Countries

Japan

Contacts

Public ContactYuta Yamamoto

Wakayama Medical University School of Medicine Department of Anatomy and Cell Biology

yuta-y@wakayama-med.ac.jp073-441-0616

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026